DKSH Transfers two China Pharma Brands to CMS

by swisscham in Engineering, Manufacturing

DKSH and China Medical System Holdings Limited (CMS), a leading pharmaceutical services provider, have signed an agreement for the transfer of Combizym and Hirudoid, two pharmaceutical brands owned and marketed by DKSH in China. CombizymÕs current market presence is almost uniquely focused on China and therefore the entire business will be handed over to CMS. Hirudoid is today marketed and distributed by DKSH on a regional basis. Here, the transaction solely comprises the purchase of Hirudoid products in mainland China. DKSH will continue to expand the brand outside of China and to source the products for the Chinese market. The Chinese pharmaceutical market is one of the worldÕs biggest, yet highly fragmented and competitive. The transaction allows DKSH to consistently implement its China strategy for sustainable, profitable growth as a Market Expansion Services provider in selective niches.

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Your Swiss Business Platform in China

SwissCham China has roughly 600 company members. Our Chamber maintains a strong relationship with the Embassy of Switzerland, Switzerland Global Enterprise, Swissnex and Switzerland Tourism. As the representative of the Swiss companies established in China, our goal is to help you to increase your business and visibility, especially amongst the Sino-Swiss business community.

Become A Member

Sign Up For Our Newsletter

  • This field is for validation purposes and should be left unchanged.
July 17, 2023
Published By in Business
July 16, 2023
Published By in Engineering / Manufacturing
July 13, 2023
Published By Consulate General of Switzerland in Guangzhou in Engineering / Manufacturing
July 3, 2023
Published By in Bilateral Relations